IONS vs SURG · rev $514.0M vs rev $16.2M
Ionis Pharmaceuticals Inc (IONS) versus Surgepays Inc (SURG) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Surgepays Inc (SURG) is a telecom services company listed on US.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
Latest reported SURG revenue for 2026-06-30 was $16.2M. Net income was $1.3M. Revenue was up 1.4% from 2026-03-31 to 2026-06-30. SURG currently screens at market cap $11.8M.
IONS currently screens at market cap $12.28B. SURG currently screens at market cap $11.8M.
Not investment advice. Open the IONS and SURG stock pages for the full models.
Not investment advice.